0001342710-21-000001.txt : 20210827 0001342710-21-000001.hdr.sgml : 20210827 20210827111814 ACCESSION NUMBER: 0001342710-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210827 DATE AS OF CHANGE: 20210827 EFFECTIVENESS DATE: 20210827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASCULAR THERAPIES INC CENTRAL INDEX KEY: 0001342710 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-411490 FILM NUMBER: 211215588 BUSINESS ADDRESS: STREET 1: 105 UNION AVENUE CITY: CRESSKILL STATE: NJ ZIP: 07626 BUSINESS PHONE: 201-266-8310 MAIL ADDRESS: STREET 1: 105 UNION AVENUE CITY: CRESSKILL STATE: NJ ZIP: 07626 FORMER COMPANY: FORMER CONFORMED NAME: VASCULAR THERAPIES LLC DATE OF NAME CHANGE: 20051027 D 1 primary_doc.xml X0708 D LIVE 0001342710 VASCULAR THERAPIES INC 105 UNION AVENUE CRESSKILL NJ NEW JERSEY 07626 201-266-8310 DELAWARE VASCULAR THERAPIES LLC Corporation true John McDermott 105 Union Aenue Cresskill NJ NEW JERSEY 07626 Executive Officer Director Sriram Iyer 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Gerald Dorros 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Allan Tessler 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Robert Croce 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Robert Flanagan 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Somus Subramaniam 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Daniel Ryan 105 Union Avenue c/o VascularTherapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Andrew Midler 105 Union Avenue c/o Vascular Therapies, Inc. Cresskill NJ NEW JERSEY 07626 Director Biotechnology Decline to Disclose 06b false 2021-08-13 false true false 0 4000000 3748712 251288 false 96 0 0 0 false VASCULAR THERAPIES INC John McDermott John McDermott Chief Executive Officer 2021-08-27